Cost-effectiveness of prenatal screening and immunization for hepatitis B virus.
about
Cost-Effectiveness of HBV and HCV Screening Strategies--A Systematic Review of Existing Modelling TechniquesCytomegalovirus in pregnancy: to screen or not to screen.Prevalence of bloodborne infective agents among people admitted to a Canadian hospitalHepatitis B virus and its sexually transmitted infection - an update.Screening for hepatitis B during pregnancy. Awareness of current recommendations among Washington hospitals.Hepatitis B in pregnancy.Cost-benefit analysis of a nationwide neonatal inoculation programme against hepatitis B in an area of intermediate endemicity.Hepatitis B vaccine by intradermal route in non responder patients: an update.Preventing perinatal transmission of HIV--costs and effectiveness of a recommended intervention.Hepatitis B and hepatitis delta virus infection in South America.Success of a program of routine prenatal screening for hepatitis B surface antigen: the first 2 years.Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study: a cluster randomized controlled trial.Screening in pregnancy.Ante-natal screening for hepatitis B surface antigen: an appraisal of its value in a low prevalence area.Hepatitis B vaccination in chronic kidney disease: review of evidence in non-dialyzed patients.Cost-benefit analysis of a nationwide inoculation programme against viral hepatitis B in an area of intermediate endemicityProposal for routine antenatal screening at 14 weeks for hepatitis B surface antigen. Dutch Study Group on Prevention of Neonatal HepatitisHepatitis B virus sero-prevalence among pregnant females in Saudi Arabia.Immunoprophylaxis of viral hepatitis.Assessing value for money in medical screening.An appraisal of the efficacy and cost effectiveness of antenatal screening for hepatitis B.Screening for hepatitis B carriers: a perspective from New Zealand.Genetic effects have a dominant role on poor responses to infant vaccination to hepatitis B virus.Vaccines for prevention of viral hepatitis.
P2860
Q26774500-68D61F6C-4B4A-4430-809D-041BE35CF74EQ26851794-A2C875A1-FCDC-4BD4-9727-24A55A72D261Q27473276-8FFE46A6-EB8D-4CA9-BFC2-C14D727AE8BAQ30235028-72E93965-1388-4147-86C6-5E093AB2540EQ33559791-90BF398F-0BB4-4D78-A6EC-FC2EF5651A6DQ33617002-40441FA5-366A-4CB2-96A1-C358E9193A80Q33701455-C1BBD391-9CF0-433A-9EE7-F879F625D775Q34036643-2026EE11-00FF-4789-A44F-8E7107748BB8Q34405202-FFDC73AD-394D-4175-8BCA-EE648B381327Q34442036-3EF89BBB-D5EB-4F00-81D5-B87D65172983Q34579821-E2796B2B-5BA0-47C8-BA6C-32D8BA81D678Q34789906-37BE4ACF-AFFA-45D8-9BB5-F6D4F7B207B6Q36415522-AA1841C7-1ED5-42F2-9AC6-BE5176F8B965Q36504655-35C85DC4-96C4-4926-A1EC-F948EFCABCD8Q36537647-61314F07-0D09-4C2E-BDBB-A2674928EB7BQ36669473-6E957683-35B4-49C6-A538-66928F08404EQ36905391-A10ACE10-4473-42FC-84CA-96506FA8E22FQ37243537-127AD415-70A8-4DB6-815A-21C2D8CF0CC5Q39486405-E1D08C29-3207-4E8D-BBBB-BD92791BD1F4Q41098791-1D6C367D-1CBB-4004-A697-A46C7E6E9A27Q41642454-7A1A796A-754B-4D9A-91D4-D22B179719B2Q41712947-7666D020-E9E4-40B5-9C49-89B8E3E0EAA6Q45352219-0E8AF768-1C0A-4F36-A3BA-1B7BF800E983Q45855062-9266249C-B19C-4460-AE35-D89C227E0C86
P2860
Cost-effectiveness of prenatal screening and immunization for hepatitis B virus.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Cost-effectiveness of prenatal screening and immunization for hepatitis B virus.
@en
Cost-effectiveness of prenatal screening and immunization for hepatitis B virus.
@nl
type
label
Cost-effectiveness of prenatal screening and immunization for hepatitis B virus.
@en
Cost-effectiveness of prenatal screening and immunization for hepatitis B virus.
@nl
prefLabel
Cost-effectiveness of prenatal screening and immunization for hepatitis B virus.
@en
Cost-effectiveness of prenatal screening and immunization for hepatitis B virus.
@nl
P1476
Cost-effectiveness of prenatal screening and immunization for hepatitis B virus.
@en
P2093
A E Washington
J A Arevalo
P304
P356
10.1001/JAMA.1988.03720030025027
P407
P577
1988-01-01T00:00:00Z